<!DOCTYPE html>
<html xmlns="https://www.w3.org/1999/xhtml" class="fa-events-icons-ready gr__clinicaltrials_gov" lang="en">



<div id="main-content">

<div class="indent2">
        	<h1 class="solo_record">An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis</h1>

  <div class="row">
    <div class="column left">
      <div class="usa-alert usa-alert-warning" style="clear:both;margin:2ex 2em;">
        <table>
          <tbody><tr>
            <td style="width:5%">
              <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/warning.png" style="width:1.3em;" alt="">
            </td>
            <td>
              The safety and scientific validity of this study is the 
responsibility of the study sponsor and investigators. Listing a study 
does not mean it has been evaluated by the U.S. Federal Government.
                            Read our <a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">disclaimer</a> for details.
            </td>
          </tr>
        </tbody></table>
      </div>      </div> 
<!--
  <div style="float:right;margin-right:4em">ClinicalTrials.gov Identifier: NCT00619866</div>
-->
    <div class="column right">
  <table style="width:90%">
  <tbody><tr><td>ClinicalTrials.gov Identifier: NCT00619866</td>
  </tr>
  <tr><td>
      
       
              <div class="not-recruiting-status">
                        <span style="display:inline;" class="term" data-term="recruitment status" title="Show definition" tabindex="0">Recruitment Status <i class="fa fa-info-circle term" aria-hidden="true" data-term="recruitment status" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: 
                    Completed
                  
                
  <div style="font-size:inherit">
  <span style="display:inline;" class="term" data-term="first posted" title="Show definition" tabindex="0">First Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="first posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: February 21, 2008</div>
      <div style="font-size:inherit">
    <span style="display:inline;" class="term" data-term="results first posted" title="Show definition" tabindex="0">Results First Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="results first posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: September 7, 2018</div>
    <div style="font-size:inherit">
  <span style="display:inline;" class="term" data-term="last update posted" title="Show definition" tabindex="0">Last Update Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="last update posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: September 7, 2018</div>

  
      </div>
  </td>
  </tr>
  </tbody></table>
  </div>
  </div>


                <div class="info-title">Sponsor:</div>
                <div class="info-text" id="sponsor"> AbbVie </div>

                              <div class="info-title">Information provided by (Responsible Party):</div>
                <div class="info-text" id="responsibleparty">AbbVie</div>
              	</div>
<br>


<div id="tabs">
    <ul id="tab-links">
		<li id="full-text"><a href="https://clinicaltrials.gov/ct2/show/study/NCT00619866?sect=X01256">Study Details</a></li>
		<li id="tabular"><a href="https://clinicaltrials.gov/ct2/show/record/NCT00619866?sect=X01256">Tabular View</a></li>
  					<li id="results" class="current"> Study Results</li>
				<li id="disclaimer"><a title="Disclaimer - opens new window" href="https://clinicaltrials.gov/ct2/about-site/disclaimer" onclick="openNewWindow('/ct2/about-site/disclaimer'); return false">Disclaimer</a></li>
		<li id="howtoread"><a title="How to Read a Study Record - opens new window" href="https://clinicaltrials.gov/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false">How to Read a Study Record</a></li>
    </ul>
</div>  <!--
<div style="background-color:#f6f6f6;margin-top:5.0ex;padding-bottom:1.5ex;"> </div>
-->

  <div id="tab-body">
  <div class="indent2" style="background-color:white;">
  <!-- Title section -->
  <div class="indent3" style="text-align:center;">
    
  
  <table class="data_table" style="margin:3ex 0;" width="80%" cellspacing="0" cellpadding="5" border="1">

        <tbody><tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">Study Type: </th>
      <td class="body3" style="text-align:left;">Interventional</td>
    </tr>
    
        <tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">Study Design: </th>
      <td class="body3" style="text-align:left;">Allocation:&nbsp;Randomized;
 &nbsp; Intervention&nbsp;Model:&nbsp;Parallel&nbsp;Assignment; &nbsp; 
Masking:&nbsp;Quadruple&nbsp;(Participant,&nbsp;Care&nbsp;Provider,&nbsp;Investigator,&nbsp;Outcomes&nbsp;Assessor);
 &nbsp; Primary&nbsp;Purpose:&nbsp;Treatment</td>
    </tr>
    
        <tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">
         Condition:       </th>
      <td class="body3" style="text-align:left;white-space:nowrap;">
                Endometriosis, Pain<br>
              </td>
    </tr>
    
        <tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">
        Interventions:       </th>
      <td class="body3" style="text-align:left;white-space:nowrap;">
                Drug: Elagolix<br>
                Drug: placebo<br>
              </td>
    </tr>
    
  </tbody></table>

  
  </div>
  
<!-- participant flow section -->
<div class="indent1">

  <br>
  <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Participant Flow</span>

  <a name="part" id="part"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">      
      <a title="Hide participant flow" href="https://clinicaltrials.gov/ct2/show/results/NCT00619866?sect=X1256#part">
        <img style="float:left" src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide Participant Flow
      </a>
    </div>

    <br>
    <span class="header3">Recruitment Details</span>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_participant_color" style="text-align:left;">
          Key information relevant to the recruitment process for the
          overall study, such as dates of the recruitment period and locations
        </th>
      </tr>
      <tr>
        <td class="body3 pale_participant_color" style="vertical-align:top;">
                      The study was conducted at 50 centers in the United States from February 2008 to August 2009.
                  </td>
      </tr>
    </tbody></table>

    <br>
    <span class="header3">Pre-Assignment Details</span>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_participant_color" style="text-align:left;">
          Significant events and approaches for the overall study
          following participant enrollment, but prior to group assignment
        </th>
      </tr>
      <tr>
        <td class="body3 pale_participant_color" style="vertical-align:top;">
                      Patients were randomized equally to oral elagolix 
150 mg or 250 mg once daily, or placebo for 12 weeks. Thereafter, 
patients originally randomized to placebo were re-randomized to one of 
the two elagolix doses and patients originally randomized to elagolix 
continued their assigned dose for an additional 12 weeks.
                  </td>
      </tr>
    </tbody></table>

    
    <br>
        
      
            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_participant_color">&nbsp;</th>
      <th class="header3 bold_participant_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day (QD) for 12 weeks. At the end of 12 weeks participants were 
re-randomized to receive one of the two doses of elagolix (150 mg or 250
 mg) QD for 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo / Elagolix 150 mg</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Participants initially randomized to placebo 
were re-randomized at week 12 to receive elagolix 150 mg for 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo / Elagolix 250 mg</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Participants initially randomized to placebo 
were re-randomized at week 12 to receive elagolix 250 mg for 12 weeks.
                      </td>
        </tr>
      </tbody></table>

      <br>
              <span class="header3">Participant Flow for 2 periods<br><br></span>
      
                    
        <span class="header3">Period 1: &nbsp; Weeks 1 - 12</span>
        <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0">
          <tbody><tr>
                          <th class="brt bold_participant_color" style="max-width:50%">&nbsp;</th>
                                                      <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Placebo
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 150 mg
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 250 mg
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Placebo / Elagolix 150 mg
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Placebo / Elagolix 250 mg
              </th>
                      </tr>
                
                
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  STARTED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;52&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;51&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;52&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;0&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;0&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  COMPLETED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;38&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;45&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;42&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;0&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;0&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  NOT COMPLETED&nbsp;                                  </th>
                                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;14&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;6&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;10&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;0&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;0&nbsp;                    </td>
                                                </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Adverse Event&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Non-compliance&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Withdrawal by Subject&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 7&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 4&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Lack of Efficacy&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Lost to Follow-up&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 4&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Sponsor Decision&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                                            </tbody></table>
      
                <br>
        
                    
        <span class="header3">Period 2: &nbsp; Weeks 13 - 24</span>
        <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0">
          <tbody><tr>
                          <th class="brt bold_participant_color" style="max-width:50%">&nbsp;</th>
                                                      <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Placebo
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 150 mg
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 250 mg
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Placebo / Elagolix 150 mg
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Placebo / Elagolix 250 mg
              </th>
                      </tr>
                
                
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  STARTED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;0&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;45&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;42&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;18&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;20&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  COMPLETED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;0&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;38&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;37&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;14&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;18&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  NOT COMPLETED&nbsp;                                  </th>
                                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;0&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;7&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;5&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;4&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;2&nbsp;                    </td>
                                                </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Adverse Event&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Protocol Deviation&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Withdrawal by Subject&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Non-compliance&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Lost to Follow-up&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                                            </tbody></table>
      
                <br>
        
              </div>
</div>
  
<!-- baseline section -->
<br>
<div class="indent1">

  <br>
  <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Baseline Characteristics</span>

  <a name="base" id="base"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">
      <a title="Hide baseline characteristics" href="https://clinicaltrials.gov/ct2/show/results/NCT00619866?sect=X0256#base">
        <img style="float:left" src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide Baseline Characteristics
      </a>
    </div>

    <br>
    <span class="header3">Population Description</span>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_baseline_color" style="text-align:left;">
          Explanation of how the number of participants for analysis was determined.
          Includes whether analysis was per protocol, intention to treat, or another method.
          Also provides relevant details such as imputation technique, as appropriate.
        </th>
      </tr>
      <tr>
        <td class="body3 pale_baseline_color" style="vertical-align:top;">
                      No text entered.
                  </td>
      </tr>
    </tbody></table>

    <br>
    
            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_baseline_color">&nbsp;</th>
      <th class="header3 bold_baseline_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Total</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Total of all reporting groups
                      </td>
        </tr>
      </tbody></table>
      
      <br>
            
          
          
    
      <span class="header3">Baseline Measures</span>
      <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0">
        <tbody><tr>
          <th class="brt bold_baseline_color" style="max-width:50%">&nbsp;</th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Placebo&nbsp;
            </th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Elagolix 150 mg&nbsp;
            </th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Elagolix 250 mg&nbsp;
            </th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Total&nbsp;
            </th>
                  </tr>
    
            
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Overall Participants Analyzed&nbsp;                <br><span class="body3">[Units:&nbsp;Participants]<br></span>               </th>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;52&nbsp;                                  </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;51&nbsp;                                  </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;52&nbsp;                                  </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;155&nbsp;                                  </td>
                          </tr>
            
              
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                  
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Age&nbsp;                <br><span class="body3">[Units:&nbsp;Years]<br>Mean (Standard Deviation)</span>               </th>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;31.2&nbsp;&nbsp;(1.0)&nbsp;                                       
               </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;30.9&nbsp;&nbsp;(1.0)&nbsp;                                       
               </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;31.0&nbsp;&nbsp;(1.0)&nbsp;                                       
               </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;31.0&nbsp;&nbsp;(0.5)&nbsp;                                       
               </td>
                          </tr>
            
              
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                  
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Sex: Female, Male&nbsp;                <br><span class="body3">[Units:&nbsp;Participants]<br>Count of Participants</span>               </th>
                                                <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                          </tr>
                          <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Female&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 52<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 51<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 52<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 155<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Male&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                                </tr>
                                        
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                  
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Race/Ethnicity, Customized&nbsp;                <br><span class="body3">[Units:&nbsp;Participants]<br>Count of Participants</span>               </th>
                                                <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                          </tr>
                          <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Asian&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 2<span class="body3">   3.8%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 2<span class="body3">   1.3%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Black&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 4<span class="body3">   7.7%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 4<span class="body3">   7.8%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 3<span class="body3">   5.8%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 11<span class="body3">   7.1%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  White&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 43<span class="body3">  82.7%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 42<span class="body3">  82.4%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 41<span class="body3">  78.8%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 126<span class="body3">  81.3%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Hispanic&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 3<span class="body3">   5.8%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 4<span class="body3">   7.8%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 6<span class="body3">  11.5%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 13<span class="body3">   8.4%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Other&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 2<span class="body3">   3.8%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 1<span class="body3">   2.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 3<span class="body3">   1.9%</span>&nbsp;                                          </td>
                                                </tr>
                                        
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                    </tbody></table>
      
      
      
        </div>
</div>
  
<!-- outcome measures section -->
<br>
<div class="indent1">

  <br>
  <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Outcome Measures</span>
  <a name="all" id="all"></a>
  <div class="header3 indent2">

            <div style="margin-top:1.0ex;">
      <a title="Hide all outcome measures" href="https://clinicaltrials.gov/ct2/show/results/NCT00619866?sect=X0156#all">
        <img style="float:left" src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide All Outcome Measures
      </a>
    </div>
    
                  <a name="outcome1" id="outcome1"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">1.&nbsp; Primary: &nbsp; </td>
            <td>Change From Baseline in the Monthly Mean Numerical 
Rating Score (NRS) for Endometriosis Pain at Week 12 &nbsp; [ Time 
Frame: Baseline and week 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Primary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in the Monthly Mean Numerical Rating Score (NRS) for Endometriosis Pain at Week 12</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 NRS is an 11-point scale used to measure endometriosis pain and was 
completed at approximately the same time each day using an electronic 
diary (e-Diary). Participants were instructed to select a single number 
between 0 (No pain) and 10 (Worst pain ever) that best described their 
endometriosis pain at its worst over the past day.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The monthly mean NRS is the average of the daily values reported during the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and week 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;38&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;44&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;45&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in the Monthly Mean 
Numerical Rating Score (NRS) for Endometriosis Pain at Week 12&nbsp;    
                    <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.88&nbsp;&nbsp;(0.18)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.19&nbsp;&nbsp;(0.18)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.25&nbsp;&nbsp;(0.18)&nbsp;                   
                                                                 </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline in the Monthly Mean Numerical Rating Score (NRS) 
for Endometriosis Pain at Week 12</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures Analysis of Covariance</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.2311</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.31</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.81 to 0.20</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.25)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Change from 
baseline in in monthly mean values of the NRS for overall 
endometriosis-associated pelvic pain was analyzed by a repeated measures
 analysis of covariance model. The model included fixed effects for 
treatment, time, the treatment-by-time interaction, a random effect for 
subject, and the baseline-by-time interaction, and the baseline value as
 a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline in the Monthly Mean Numerical Rating Score (NRS) 
for Endometriosis Pain at Week 12</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures Analysis of Covariance</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.1521</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.36</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.86 to 0.14</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.25)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Change from 
baseline in in monthly mean values of the NRS for overall 
endometriosis-associated pelvic pain was analyzed by a repeated measures
 analysis of covariance model. The model included fixed effects for 
treatment, time, the treatment-by-time interaction, a random effect for 
subject, and the baseline-by-time interaction, and the baseline value as
 a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome2" id="outcome2"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">2.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in the Monthly Mean Numerical 
Rating Score (NRS) for Endometriosis Pain &nbsp; [ Time Frame: Baseline 
and weeks 4 and 8 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in the Monthly Mean Numerical Rating Score (NRS) for Endometriosis Pain</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 NRS is an 11-point scale used to measure endometriosis pain and was 
completed at approximately the same time each day using an electronic 
diary (e-Diary). Participants were instructed to select a single number 
between 0 (No pain) and 10 (Worst pain ever) that best described their 
endometriosis pain at its worst over the past day.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The monthly mean NRS is the average of the daily values reported during the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4 and 8 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in the Monthly Mean 
Numerical Rating Score (NRS) for Endometriosis Pain&nbsp;               
         <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.60&nbsp;&nbsp;(0.17)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.90&nbsp;&nbsp;(0.17)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.83&nbsp;&nbsp;(0.17)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.71&nbsp;&nbsp;(0.18)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.23&nbsp;&nbsp;(0.17)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.94&nbsp;&nbsp;(0.17)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in the Monthly Mean Numerical Rating Score (NRS) for Endometriosis Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.2041</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.30</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.77 to 0.17</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.24)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
4. Change from baseline in in monthly mean values of the NRS for overall
 endometriosis-associated pelvic pain was analyzed by a repeated 
measures analysis of covariance model. The model included fixed effects 
for treatment, time, the treatment-by-time interaction, a random effect 
for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in the Monthly Mean Numerical Rating Score (NRS) for Endometriosis Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.3375</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.23</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.69 to 0.24</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.24)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
4. Change from baseline in in monthly mean values of the NRS for overall
 endometriosis-associated pelvic pain was analyzed by a repeated 
measures analysis of covariance model. The model included fixed effects 
for treatment, time, the treatment-by-time interaction, a random effect 
for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in the Monthly Mean Numerical Rating Score (NRS) for Endometriosis Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0354</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.52</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.01 to -0.04</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.25)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
8. Change from baseline in in monthly mean values of the NRS for overall
 endometriosis-associated pelvic pain was analyzed by a repeated 
measures analysis of covariance model. The model included fixed effects 
for treatment, time, the treatment-by-time interaction, a random effect 
for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 4 for Change From Baseline in the Monthly Mean Numerical Rating Score (NRS) for Endometriosis Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.3618</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.23</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.71 to 0.26</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.25)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
8. Change from baseline in in monthly mean values of the NRS for overall
 endometriosis-associated pelvic pain was analyzed by a repeated 
measures analysis of covariance model. The model included fixed effects 
for treatment, time, the treatment-by-time interaction, a random effect 
for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome3" id="outcome3"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">3.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in the Monthly Peak Numerical 
Rating Score (NRS) for Endometriosis Pain &nbsp; [ Time Frame: Baseline 
and Weeks 4, 8, and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in the Monthly Peak Numerical Rating Score (NRS) for Endometriosis Pain</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 NRS is an 11-point scale used to measure endometriosis pain and was 
completed at approximately the same time each day using an electronic 
diary (e-Diary). Participants were instructed to select a single number 
between 0 (No pain) and 10 (Worst pain ever) that best described their 
endometriosis pain at its worst over the past day.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The monthly peak NRS is the maximum of the daily values reported during the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and Weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in the Monthly Peak 
Numerical Rating Score (NRS) for Endometriosis Pain&nbsp;               
         <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.27&nbsp;&nbsp;(0.32)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.39&nbsp;&nbsp;(0.32)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.58&nbsp;&nbsp;(0.32)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.25&nbsp;&nbsp;(0.34)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.94&nbsp;&nbsp;(0.33)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-2.41&nbsp;&nbsp;(0.33)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.30&nbsp;&nbsp;(0.36)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-2.45&nbsp;&nbsp;(0.34)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-2.74&nbsp;&nbsp;(0.34)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in the Monthly Peak Numerical Rating Score (NRS) for Endometriosis Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.7990</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.12</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.01 to 0.78</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.46)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
4. Change from baseline in in monthly peak values of the NRS for overall
 endometriosis-associated pelvic pain was analyzed by a repeated 
measures analysis of covariance model. The model included fixed effects 
for treatment, time, the treatment-by-time interaction, a random effect 
for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in the Monthly Peak Numerical Rating Score (NRS) for Endometriosis Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.5042</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.31</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.21 to 0.59</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.46)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
4. Change from baseline in in monthly peak values of the NRS for overall
 endometriosis-associated pelvic pain was analyzed by a repeated 
measures analysis of covariance model. The model included fixed effects 
for treatment, time, the treatment-by-time interaction, a random effect 
for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in the Monthly Peak Numerical Rating Score (NRS) for Endometriosis Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.1459</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.69</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.63 to 0.24</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.48)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
8. Change from baseline in in monthly peak values of the NRS for overall
 endometriosis-associated pelvic pain was analyzed by a repeated 
measures analysis of covariance model. The model included fixed effects 
for treatment, time, the treatment-by-time interaction, a random effect 
for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 4 for Change From Baseline in the Monthly Peak Numerical Rating Score (NRS) for Endometriosis Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0163</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.16</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.10 to -0.21</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.48)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
8. Change from baseline in in monthly peak values of the NRS for overall
 endometriosis-associated pelvic pain was analyzed by a repeated 
measures analysis of covariance model. The model included fixed effects 
for treatment, time, the treatment-by-time interaction, a random effect 
for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 5 for Change From Baseline in the Monthly Peak Numerical Rating Score (NRS) for Endometriosis Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0207</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.15</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.13 to -0.18</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.50)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
12. Change from baseline in in monthly peak values of the NRS for 
overall endometriosis-associated pelvic pain was analyzed by a repeated 
measures analysis of covariance model. The model included fixed effects 
for treatment, time, the treatment-by-time interaction, a random effect 
for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 6 for Change From Baseline in the Monthly Peak Numerical Rating Score (NRS) for Endometriosis Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0038</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.44</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.42 to -0.47</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.50)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
12. Change from baseline in in monthly peak values of the NRS for 
overall endometriosis-associated pelvic pain was analyzed by a repeated 
measures analysis of covariance model. The model included fixed effects 
for treatment, time, the treatment-by-time interaction, a random effect 
for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome4" id="outcome4"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">4.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in the Monthly Mean Non-menstrual Pelvic Pain Score &nbsp; [ Time Frame: Baseline and weeks 4, 8, and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in the Monthly Mean Non-menstrual Pelvic Pain Score</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">Participants
 assessed their pelvic pain not related to menses and its impact on 
their daily activities at approximately the same time every day in an 
e-Diary according to the following response options:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">0 = No pelvic pain</li>
    <li style="margin-top:0.7ex;">1 = Mild pelvic pain; subject could not do some of the things she usually does</li>
    <li style="margin-top:0.7ex;">2 = Moderate pelvic pain; subject could not do many of the things she usually does</li>
    <li style="margin-top:0.7ex;">3 = Severe pelvic pain; subject could not do most or all of the things she usually does.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">The monthly mean 
non-menstrual pelvic pain score is the average of the daily values 
reported during the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in the Monthly Mean Non-menstrual Pelvic Pain Score&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.14&nbsp;&nbsp;(0.05)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.18&nbsp;&nbsp;(0.05)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.16&nbsp;&nbsp;(0.05)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.12&nbsp;&nbsp;(0.05)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.30&nbsp;&nbsp;(0.05)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.17&nbsp;&nbsp;(0.05)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.22&nbsp;&nbsp;(0.06)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.27&nbsp;&nbsp;(0.05)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.25&nbsp;&nbsp;(0.05)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in the Monthly Mean Non-menstrual Pelvic Pain Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.5744</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.04</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.18 to 0.10</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.07)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
4. Change from baseline in non-menstrual pelvic pain score was analyzed 
by a repeated measures analysis of covariance model. The model included 
fixed effects for treatment, time, the treatment-by-time interaction, a 
random effect for subject, and the baseline-by-time interaction, and the
 baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in the Monthly Mean Non-menstrual Pelvic Pain Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.7280</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.03</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.17 to 0.12</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.07)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
4. Change from baseline in non-menstrual pelvic pain score was analyzed 
by a repeated measures analysis of covariance model. The model included 
fixed effects for treatment, time, the treatment-by-time interaction, a 
random effect for subject, and the baseline-by-time interaction, and the
 baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in the Monthly Mean Non-menstrual Pelvic Pain Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0195</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.18</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.32 to -0.03</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.07)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
8. Change from baseline in non-menstrual pelvic pain score was analyzed 
by a repeated measures analysis of covariance model. The model included 
fixed effects for treatment, time, the treatment-by-time interaction, a 
random effect for subject, and the baseline-by-time interaction, and the
 baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 4 for Change From Baseline in the Monthly Mean Non-menstrual Pelvic Pain Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.5589</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.04</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.19 to 0.10</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.08)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
8. Change from baseline in non-menstrual pelvic pain score was analyzed 
by a repeated measures analysis of covariance model. The model included 
fixed effects for treatment, time, the treatment-by-time interaction, a 
random effect for subject, and the baseline-by-time interaction, and the
 baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 5 for Change From Baseline in the Monthly Mean Non-menstrual Pelvic Pain Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.5558</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.05</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.20 to 0.11</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.08)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
12. Change from baseline in non-menstrual pelvic pain score was analyzed
 by a repeated measures analysis of covariance model. The model included
 fixed effects for treatment, time, the treatment-by-time interaction, a
 random effect for subject, and the baseline-by-time interaction, and 
the baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 6 for Change From Baseline in the Monthly Mean Non-menstrual Pelvic Pain Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.7121</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.03</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.18 to 0.12</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.08)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
12. Change from baseline in non-menstrual pelvic pain score was analyzed
 by a repeated measures analysis of covariance model. The model included
 fixed effects for treatment, time, the treatment-by-time interaction, a
 random effect for subject, and the baseline-by-time interaction, and 
the baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome5" id="outcome5"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">5.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in the Monthly Mean Dysmenorrhea Score &nbsp; [ Time Frame: Baseline and Weeks 4, 8, and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in the Monthly Mean Dysmenorrhea Score</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">Participants
 assessed dysmenorrhea (pain during menstruation) and its impact on 
their daily activities at approximately the same time each day in an 
e-Diary according to the following response options:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">Subject is not having her period</li>
    <li style="margin-top:0.7ex;">0 = No pain related to period</li>
    <li style="margin-top:0.7ex;">1 = Mild pain related to period; subject could not do some of the things she usually does</li>
    <li style="margin-top:0.7ex;">2 = Moderate pain related to period; subject could not do many of the things she usually does</li>
    <li style="margin-top:0.7ex;">3 = Severe pain related to period; subject could not do most of or all of the things she usually does.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">The monthly mean dysmenorrhea score is the average of the daily values reported during the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and Weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in the Monthly Mean Dysmenorrhea Score&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.20&nbsp;&nbsp;(0.09)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.49&nbsp;&nbsp;(0.09)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.40&nbsp;&nbsp;(0.09)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.29&nbsp;&nbsp;(0.10)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.71&nbsp;&nbsp;(0.09)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.79&nbsp;&nbsp;(0.09)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.24&nbsp;&nbsp;(0.10)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.68&nbsp;&nbsp;(0.10)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.76&nbsp;&nbsp;(0.10)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in the Monthly Mean Dysmenorrhea Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0286</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.28</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.54 to -0.03</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.13)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
4. Change from baseline in dysmenorrhea score was analyzed by a repeated
 measures analysis of covariance model. The model included fixed effects
 for treatment, time, the treatment-by-time interaction, a random effect
 for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in the Monthly Mean Dysmenorrhea Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.1210</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.20</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.45 to 0.05</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.13)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
4. Change from baseline in dysmenorrhea score was analyzed by a repeated
 measures analysis of covariance model. The model included fixed effects
 for treatment, time, the treatment-by-time interaction, a random effect
 for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in the Monthly Mean Dysmenorrhea Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0024</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.42</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.68 to -0.15</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.14)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
8. Change from baseline in dysmenorrhea score was analyzed by a repeated
 measures analysis of covariance model. The model included fixed effects
 for treatment, time, the treatment-by-time interaction, a random effect
 for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 4 for Change From Baseline in the Monthly Mean Dysmenorrhea Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0003</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.49</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.76 to -0.22</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.14)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
8. Change from baseline in dysmenorrhea score was analyzed by a repeated
 measures analysis of covariance model. The model included fixed effects
 for treatment, time, the treatment-by-time interaction, a random effect
 for subject, and the baseline-by-time interaction, and the baseline 
value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 5 for Change From Baseline in the Monthly Mean Dysmenorrhea Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0021</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.44</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.72 to -0.16</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.14)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
12. Change from baseline in dysmenorrhea score was analyzed by a 
repeated measures analysis of covariance model. The model included fixed
 effects for treatment, time, the treatment-by-time interaction, a 
random effect for subject, and the baseline-by-time interaction, and the
 baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 6 for Change From Baseline in the Monthly Mean Dysmenorrhea Score</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0003</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.52</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.80 to -0.24</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.14)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
12. Change from baseline in dysmenorrhea score was analyzed by a 
repeated measures analysis of covariance model. The model included fixed
 effects for treatment, time, the treatment-by-time interaction, a 
random effect for subject, and the baseline-by-time interaction, and the
 baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome6" id="outcome6"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">6.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in the Monthly Mean Total of 
Dysmenorrhea and Non-menstrual Pelvic Pain Scores &nbsp; [ Time Frame: 
Baseline and Weeks 4, 8, and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in the Monthly Mean Total of Dysmenorrhea and Non-menstrual Pelvic Pain Scores</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">Participants
 assessed dysmenorrhea and pelvic pain not related to menses and their 
impact on daily activities at approximately the same time every day on a
 4-point scale (0 = none, 1 = mild, 2 = moderate, and 3 = severe) in an 
e-Diary.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The sum of the 
dysmenorrhea and non-menstrual pelvic pain scores on each day were 
calculated to create a daily total score. On days the participant was 
not having her period, the dysmenorrhea score was not defined; hence, 
the total score was equal to the non-menstrual pelvic pain score (range 0
 to 3). On days where the participant recorded menstruation the total 
score ranged from 0 to 6, where higher scores indicate more severe pain.
 The monthly mean sum of dysmenorrhea and non-menstrual pelvic pain 
scores is the average of the daily values reported during the 4 weeks 
prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and Weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in the Monthly Mean Total 
of Dysmenorrhea and Non-menstrual Pelvic Pain Scores&nbsp;              
          <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.18&nbsp;&nbsp;(0.06)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.34&nbsp;&nbsp;(0.06)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.29&nbsp;&nbsp;(0.06)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.18&nbsp;&nbsp;(0.06)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.48&nbsp;&nbsp;(0.06)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.33&nbsp;&nbsp;(0.06)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.27&nbsp;&nbsp;(0.07)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.44&nbsp;&nbsp;(0.06)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.41&nbsp;&nbsp;(0.06)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in the Monthly Mean Total of Dysmenorrhea and Non-menstrual Pelvic Pain Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0603</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.16</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.34 to 0.01</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.09)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
4. Change from baseline in total of non-menstrual pelvic pain and 
dysmenorrhea scores was analyzed by a repeated measures analysis of 
covariance model. The model included fixed effects for treatment, time, 
the treatment-by-time interaction, a random effect for subject, and the 
baseline-by-time interaction, and the baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in the Monthly Mean Total of Dysmenorrhea and Non-menstrual Pelvic Pain Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.1855</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.12</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.29 to 0.06</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.09)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
4. Change from baseline in total of non-menstrual pelvic pain and 
dysmenorrhea scores was analyzed by a repeated measures analysis of 
covariance model. The model included fixed effects for treatment, time, 
the treatment-by-time interaction, a random effect for subject, and the 
baseline-by-time interaction, and the baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in the Monthly Mean Total of Dysmenorrhea and Non-menstrual Pelvic Pain Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0012</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.30</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.48 to -0.12</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.09)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
8. Change from baseline in total of non-menstrual pelvic pain and 
dysmenorrhea scores was analyzed by a repeated measures analysis of 
covariance model. The model included fixed effects for treatment, time, 
the treatment-by-time interaction, a random effect for subject, and the 
baseline-by-time interaction, and the baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 4 for Change From Baseline in the Monthly Mean Total of Dysmenorrhea and Non-menstrual Pelvic Pain Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.1002</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.15</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.33 to 0.03</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.09)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
8. Change from baseline in total of non-menstrual pelvic pain and 
dysmenorrhea scores was analyzed by a repeated measures analysis of 
covariance model. The model included fixed effects for treatment, time, 
the treatment-by-time interaction, a random effect for subject, and the 
baseline-by-time interaction, and the baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 5 for Change From Baseline in the Monthly Mean Total of Dysmenorrhea and Non-menstrual Pelvic Pain Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.0568</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.18</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.36 to 0.01</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.09)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
12. Change from baseline in total of non-menstrual pelvic pain and 
dysmenorrhea scores was analyzed by a repeated measures analysis of 
covariance model. The model included fixed effects for treatment, time, 
the treatment-by-time interaction, a random effect for subject, and the 
baseline-by-time interaction, and the baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 6 for Change From Baseline in the Monthly Mean Total of Dysmenorrhea and Non-menstrual Pelvic Pain Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 250 mg</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Repeated Measures ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.1190</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.15</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.33 to 0.04</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.09)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Analysis at week 
12. Change from baseline in total of non-menstrual pelvic pain and 
dysmenorrhea scores was analyzed by a repeated measures analysis of 
covariance model. The model included fixed effects for treatment, time, 
the treatment-by-time interaction, a random effect for subject, and the 
baseline-by-time interaction, and the baseline value as a covariate.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference = Elagolix - Placebo
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome7" id="outcome7"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">7.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Days With No Pain Based on NRS &nbsp; [ Time Frame: Baseline and weeks 4, 8 and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Days With No Pain Based on NRS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 NRS is an 11-point scale used to measure endometriosis pain and was 
completed at approximately the same time each day using an electronic 
diary (e-Diary). Participants were instructed to select a single number 
between 0 (No pain) and 10 (Worst pain ever) that best described their 
endometriosis pain at its worst over the past day.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The percentage of days a
 participant reported a value of zero (or “no pain”) for the NRS was 
calculated for the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8 and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Days With No Pain Based on NRS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;days]<br>Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Baseline&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Baseline&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;27.600&nbsp;&nbsp;(3.588)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;25.380&nbsp;&nbsp;(3.564)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;25.515&nbsp;&nbsp;(3.493)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;35.252&nbsp;&nbsp;(4.118)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;36.401&nbsp;&nbsp;(4.606)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;32.355&nbsp;&nbsp;(4.604)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;40.861&nbsp;&nbsp;(4.671)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;43.780&nbsp;&nbsp;(5.114)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;36.737&nbsp;&nbsp;(5.467)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;47.431&nbsp;&nbsp;(4.955)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;44.841&nbsp;&nbsp;(5.857)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;41.760&nbsp;&nbsp;(5.796)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percentage of Days With No Pain Based on NRS</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome8" id="outcome8"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">8.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Days With No Pain Based Based on 
Non-menstrual Pelvic Pain Daily Assessment &nbsp; [ Time Frame: Baseline
 and weeks 4, 8 and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Days With No Pain Based Based on Non-menstrual Pelvic Pain Daily Assessment</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">Participants
 assessed their pelvic pain not related to menses and its impact on 
their daily activities at approximately the same time every day in an 
e-Diary according to the following response options:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">0 = No pelvic pain</li>
    <li style="margin-top:0.7ex;">1 = Mild pelvic pain; subject could not do some of the things she usually does</li>
    <li style="margin-top:0.7ex;">2 = Moderate pelvic pain; subject could not do many of the things she usually does</li>
    <li style="margin-top:0.7ex;">3 = Severe pelvic pain; subject could not do most or all of the things she usually does.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">The percentage of days a
 participant reported a value of zero ("no pain") for non-menstrual 
pelvic pain was calculated for the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8 and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Days With No Pain Based Based on 
Non-menstrual Pelvic Pain Daily Assessment&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;days]<br>Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Baseline&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Baseline&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;34.939&nbsp;&nbsp;(3.831)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;36.821&nbsp;&nbsp;(4.041)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;38.530&nbsp;&nbsp;(4.065)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;42.986&nbsp;&nbsp;(4.229)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;45.469&nbsp;&nbsp;(4.968)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;44.443&nbsp;&nbsp;(4.905)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;46.228&nbsp;&nbsp;(4.777)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;54.967&nbsp;&nbsp;(5.291)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;47.524&nbsp;&nbsp;(5.367)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;54.270&nbsp;&nbsp;(4.768)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;53.836&nbsp;&nbsp;(6.077)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;50.061&nbsp;&nbsp;(5.496)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percentage of Days With No Pain Based Based on Non-menstrual Pelvic Pain Daily Assessment</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome9" id="outcome9"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">9.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Days With No Pain Based Based on 
Dysmenorrhea Daily Assessment &nbsp; [ Time Frame: Baseline and weeks 4,
 8 and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Days With No Pain Based Based on Dysmenorrhea Daily Assessment</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">Participants
 assessed dysmenorrhea (pain during menstruation) and its impact on 
their daily activities at approximately the same time each day in an 
e-Diary according to the following response options:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">Subject is not having her period</li>
    <li style="margin-top:0.7ex;">0 = No pain related to period</li>
    <li style="margin-top:0.7ex;">1 = Mild pain related to period; subject could not do some of the things she usually does</li>
    <li style="margin-top:0.7ex;">2 = Moderate pain related to period; subject could not do many of the things she usually does</li>
    <li style="margin-top:0.7ex;">= Severe pain related to period; subject could not do most of or all of the things she usually does.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">The percentage of days a
 participant reported a value of zero ("no pain") for dysmenorrhea was 
calculated for the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8 and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Days With No Pain Based Based on 
Dysmenorrhea Daily Assessment&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;days]<br>Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Baseline&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Baseline&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;26.350&nbsp;&nbsp;(3.710)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;14.340&nbsp;&nbsp;(2.154)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;21.086&nbsp;&nbsp;(3.210)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;30.513&nbsp;&nbsp;(4.435)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;43.411&nbsp;&nbsp;(5.775)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;39.475&nbsp;&nbsp;(5.509)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;35.057&nbsp;&nbsp;(5.135)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;56.952&nbsp;&nbsp;(6.016)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;67.411&nbsp;&nbsp;(6.190)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;34.439&nbsp;&nbsp;(5.000)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;61.658&nbsp;&nbsp;(6.717)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;66.186&nbsp;&nbsp;(6.336)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percentage of Days With No Pain Based Based on Dysmenorrhea Daily Assessment</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome10" id="outcome10"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">10.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Days With No Pain Based Based on Total 
Score of Non-menstrual Pelvic Pain and Dysmenorrhea Daily Assessment 
&nbsp; [ Time Frame: Baseline and weeks 4, 8 and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Days With No Pain Based Based on Total Score of Non-menstrual Pelvic Pain and Dysmenorrhea Daily Assessment</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">Participants
 assessed dysmenorrhea and pelvic pain not related to menses and their 
impact on daily activities at approximately the same time every day in 
an e-Diary on a 4-point scale (0 = none, 1 = mild, 2 = moderate, and 3 =
 severe). The sum of the dysmenorrhea and non-menstrual pelvic pain 
scores on each day were calculated to create a daily total score. On 
days the participant was not having her period, the dysmenorrhea score 
was not defined; hence, the total score was equal to the non-menstrual 
pelvic pain score (range 0 to 3). On days where the participant recorded
 menstruation the total score ranged from 0 to 6, where higher scores 
indicate more severe pain.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The percentage of days a
 participant reported a value of zero ("no pain") for the non-menstrual 
pelvic pain and dysmenorrhea total score was calculated for the 4 weeks 
prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8 and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Days With No Pain Based Based on 
Total Score of Non-menstrual Pelvic Pain and Dysmenorrhea Daily 
Assessment&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;days]<br>Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Baseline&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Baseline&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;33.009&nbsp;&nbsp;(3.690)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;32.940&nbsp;&nbsp;(3.649)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;35.967&nbsp;&nbsp;(3.815)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;39.586&nbsp;&nbsp;(4.058)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;44.020&nbsp;&nbsp;(4.825)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;43.230&nbsp;&nbsp;(4.844)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;43.961&nbsp;&nbsp;(4.607)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;53.526&nbsp;&nbsp;(5.200)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;47.108&nbsp;&nbsp;(5.380)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;50.340&nbsp;&nbsp;(4.552)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;52.584&nbsp;&nbsp;(5.999)&nbsp;                                   
                                                                   </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    
&nbsp;49.409&nbsp;&nbsp;(5.494)&nbsp;                                   
                                                                   </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical 
analysis provided for Percentage of Days With No Pain Based Based on 
Total Score of Non-menstrual Pelvic Pain and Dysmenorrhea Daily 
Assessment</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome11" id="outcome11"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">11.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in the Percentage of Days of Any Analgesic Use &nbsp; [ Time Frame: Baseline and Weeks 4, 8, and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in the Percentage of Days of Any Analgesic Use</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 daily use of endometriosis analgesics was reported by participants 
daily using the e-Diary. Participants reported whether the medication 
was over-the-counter (OTC) or prescription, and, if prescription, 
whether the medication was a narcotic.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The percentage of days 
of any analgesic use is defined as the number of days in the 4 weeks 
prior to each study visit that the participant reported the use of an 
analgesic, divided by the number of study days in the interval that the 
participant provided an e-Diary report regarding the use of 
endometriosis analgesics (including a response of “none”).</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and Weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in the Percentage of Days of Any Analgesic Use&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;days]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.8&nbsp;&nbsp;(2.3)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-8.7&nbsp;&nbsp;(2.3)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-6.8&nbsp;&nbsp;(2.3)&nbsp;   
                                                                        
                           </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.8&nbsp;&nbsp;(2.4)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-12.6&nbsp;&nbsp;(2.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-10.4&nbsp;&nbsp;(2.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-6.1&nbsp;&nbsp;(2.5)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-10.5&nbsp;&nbsp;(2.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-13.9&nbsp;&nbsp;(2.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in the Percentage of Days of Any Analgesic Use</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome12" id="outcome12"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">12.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in the Percentage of Days of 
Prescription Analgesic Use &nbsp; [ Time Frame: Baseline and Weeks 4, 8,
 and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in the Percentage of Days of Prescription Analgesic Use</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 daily use of endometriosis analgesics was reported by participants 
daily using the e-Diary. Participants reported whether the medication 
was over-the-counter (OTC) or prescription, and, if prescription, 
whether the medication was a narcotic.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The percentage of days 
of prescription analgesic use is defined as the number of days in the 4 
weeks prior to each study visit that the participant reported the use of
 a prescription analgesic, divided by the number of study days in the 
interval that the participant provided an e-Diary report regarding the 
use of endometriosis analgesics (including a response of “none”).</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and Weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in the Percentage of Days 
of Prescription Analgesic Use&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;days]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(1.2)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.0&nbsp;&nbsp;(1.2)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-2.3&nbsp;&nbsp;(1.2)&nbsp;   
                                                                        
                           </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(1.4)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.2&nbsp;&nbsp;(1.3)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.2&nbsp;&nbsp;(1.4)&nbsp;   
                                                                        
                           </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-2.1&nbsp;&nbsp;(1.6)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-2.6&nbsp;&nbsp;(1.6)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.3&nbsp;&nbsp;(1.6)&nbsp;   
                                                                        
                           </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in the Percentage of Days of Prescription Analgesic Use</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome13" id="outcome13"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">13.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in the Percentage of Days of Narcotic Analgesic Use &nbsp; [ Time Frame: Baseline and Weeks 4, 8, and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in the Percentage of Days of Narcotic Analgesic Use</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 daily use of endometriosis analgesics was reported by participants 
daily using the e-Diary. Participants reported whether the medication 
was over-the-counter (OTC) or prescription, and, if prescription, 
whether the medication was a narcotic.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The percentage of days 
of narcotic analgesic use is defined as the number of days in the 4 
weeks prior to each study visit that the participant reported the use of
 a narcotic analgesic, divided by the number of study days in the 
interval that the participant provided an e-Diary report regarding the 
use of endometriosis analgesics (including a response of “none”).</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and Weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in the Percentage of Days of Narcotic Analgesic Use&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;days]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(1.1)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-2.5&nbsp;&nbsp;(1.2)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-2.1&nbsp;&nbsp;(1.2)&nbsp;   
                                                                        
                           </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(1.2)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.8&nbsp;&nbsp;(1.2)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.0&nbsp;&nbsp;(1.2)&nbsp;   
                                                                        
                           </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.7&nbsp;&nbsp;(1.3)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.3&nbsp;&nbsp;(1.3)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.6&nbsp;&nbsp;(1.3)&nbsp;   
                                                                        
                           </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in the Percentage of Days of Narcotic Analgesic Use</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome14" id="outcome14"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">14.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants With 30% Decrease From 
Baseline in Monthly Mean NRS &nbsp; [ Time Frame: Baseline and weeks 4, 8
 and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Participants With 30% Decrease From Baseline in Monthly Mean NRS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 NRS is an 11-point scale used to measure endometriosis pain and was 
completed at approximately the same time each day using an electronic 
diary (e-Diary). Participants were instructed to select a single number 
between 0 (No pain) and 10 (Worst pain ever) that best described their 
endometriosis pain at its worst over the past day.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The monthly mean NRS is the average of the daily values reported during the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8 and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants With 30% Decrease 
From Baseline in Monthly Mean NRS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br>Number (95% Confidence Interval)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;38.5&nbsp;<br>
                                      &nbsp;(25.2&nbsp;to&nbsp;51.7)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;43.1&nbsp;<br>
                                      &nbsp;(29.5&nbsp;to&nbsp;56.7)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;47.1&nbsp;<br>
                                      &nbsp;(33.4&nbsp;to&nbsp;60.8)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;54.5&nbsp;<br>
                                      &nbsp;(39.8&nbsp;to&nbsp;69.3)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;60.4&nbsp;<br>
                                      &nbsp;(46.6&nbsp;to&nbsp;74.3)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;51.1&nbsp;<br>
                                      &nbsp;(36.8&nbsp;to&nbsp;65.4)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;60.5&nbsp;<br>
                                      &nbsp;(45.0&nbsp;to&nbsp;76.1)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;63.6&nbsp;<br>
                                      &nbsp;(49.4&nbsp;to&nbsp;77.9)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;60.0&nbsp;<br>
                                      &nbsp;(45.7&nbsp;to&nbsp;74.3)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percentage of Participants With 30% Decrease From Baseline in Monthly Mean NRS</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome15" id="outcome15"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">15.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants With 30% Decrease From 
Baseline in Monthly Peak NRS &nbsp; [ Time Frame: Baseline and weeks 4, 8
 and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Participants With 30% Decrease From Baseline in Monthly Peak NRS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 NRS is an 11-point scale used to measure endometriosis pain and was 
completed at approximately the same time each day using an electronic 
diary (e-Diary). Participants were instructed to select a single number 
between 0 (No pain) and 10 (Worst pain ever) that best described their 
endometriosis pain at its worst over the past day.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The monthly peak NRS is the maximum of the daily values reported during the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8 and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants With 30% Decrease 
From Baseline in Monthly Peak NRS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br>Number (95% Confidence Interval)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;30.8&nbsp;<br>
                                      &nbsp;(18.2&nbsp;to&nbsp;43.3)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;35.3&nbsp;<br>
                                      &nbsp;(22.2&nbsp;to&nbsp;48.4)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;31.4&nbsp;<br>
                                      &nbsp;(18.6&nbsp;to&nbsp;44.1)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;38.6&nbsp;<br>
                                      &nbsp;(24.2&nbsp;to&nbsp;53.0)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;43.8&nbsp;<br>
                                      &nbsp;(29.7&nbsp;to&nbsp;57.8)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;48.9&nbsp;<br>
                                      &nbsp;(34.6&nbsp;to&nbsp;63.2)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;36.8&nbsp;<br>
                                      &nbsp;(21.5&nbsp;to&nbsp;52.2)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;47.7&nbsp;<br>
                                      &nbsp;(33.3&nbsp;to&nbsp;62.5)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;57.8&nbsp;<br>
                                      &nbsp;(43.3&nbsp;to&nbsp;72.2)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percentage of Participants With 30% Decrease From Baseline in Monthly Peak NRS</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome16" id="outcome16"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">16.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants With 50% Decrease From 
Baseline in Monthly Mean NRS &nbsp; [ Time Frame: Baseline and weeks 4, 8
 and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Participants With 50% Decrease From Baseline in Monthly Mean NRS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 NRS is an 11-point scale used to measure endometriosis pain and was 
completed at approximately the same time each day using an electronic 
diary (e-Diary). Participants were instructed to select a single number 
between 0 (No pain) and 10 (Worst pain ever) that best described their 
endometriosis pain at its worst over the past day.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The monthly mean NRS is the average of the daily values reported during the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8 and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants With 50% Decrease 
From Baseline in Monthly Mean NRS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br>Number (95% Confidence Interval)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;21.2&nbsp;<br>
                                      &nbsp;(10.1&nbsp;to&nbsp;32.3)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;37.3&nbsp;<br>
                                      &nbsp;(24.0&nbsp;to&nbsp;50.5)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;25.5&nbsp;<br>
                                      &nbsp;(13.5&nbsp;to&nbsp;37.5)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;36.4&nbsp;<br>
                                      &nbsp;(22.1&nbsp;to&nbsp;50.6)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;45.8&nbsp;<br>
                                      &nbsp;(31.7&nbsp;to&nbsp;59.9)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;38.3&nbsp;<br>
                                      &nbsp;(24.4&nbsp;to&nbsp;52.2)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;36.8&nbsp;<br>
                                      &nbsp;(21.5&nbsp;to&nbsp;52.2)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;45.5&nbsp;<br>
                                      &nbsp;(30.7&nbsp;to&nbsp;60.2)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;44.4&nbsp;<br>
                                      &nbsp;(29.9&nbsp;to&nbsp;59.0)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percentage of Participants With 50% Decrease From Baseline in Monthly Mean NRS</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome17" id="outcome17"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">17.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants With 50% Decrease From 
Baseline in Monthly Peak NRS &nbsp; [ Time Frame: Baseline and weeks 4, 8
 and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Participants With 50% Decrease From Baseline in Monthly Peak NRS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 NRS is an 11-point scale used to measure endometriosis pain and was 
completed at approximately the same time each day using an electronic 
diary (e-Diary). Participants were instructed to select a single number 
between 0 (No pain) and 10 (Worst pain ever) that best described their 
endometriosis pain at its worst over the past day.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The monthly peak NRS is the maximum of the daily values reported during the 4 weeks prior to each visit.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8 and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants With 50% Decrease 
From Baseline in Monthly Peak NRS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br>Number (95% Confidence Interval)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;11.5&nbsp;<br>
                                      &nbsp;(2.9&nbsp;to&nbsp;20.2)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;17.6&nbsp;<br>
                                      &nbsp;(7.2&nbsp;to&nbsp;28.1)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;19.6&nbsp;<br>
                                      &nbsp;(8.7&nbsp;to&nbsp;30.5)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;11.4&nbsp;<br>
                                      &nbsp;(2.0&nbsp;to&nbsp;20.7)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;25.0&nbsp;<br>
                                      &nbsp;(12.8&nbsp;to&nbsp;37.2)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;36.2&nbsp;<br>
                                      &nbsp;(22.4&nbsp;to&nbsp;49.9)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;23.7&nbsp;<br>
                                      &nbsp;(10.2&nbsp;to&nbsp;37.2)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;34.1&nbsp;<br>
                                      &nbsp;(20.1&nbsp;to&nbsp;48.1)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;42.2&nbsp;<br>
                                      &nbsp;(27.8&nbsp;to&nbsp;56.7)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percentage of Participants With 50% Decrease From Baseline in Monthly Peak NRS</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome18" id="outcome18"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">18.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in Dyspareunia Component of the 
Composite Pelvic Signs and Symptoms Score (CPSSS) &nbsp; [ Time Frame: 
Baseline and Weeks 4, 8, and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in Dyspareunia Component of the Composite Pelvic Signs and Symptoms Score (CPSSS)</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 CPSSS consists of 5 components that address dysmenorrhea, dyspareunia, 
non-menstrual pelvic pain, pelvic tenderness, and pelvic induration. To 
assess dyspareunia (painful intercourse) participants were asked to 
select the best description of pain during sexual intercourse over the 
past 28 days using the following response categories:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">0 = Absent; No discomfort during sexual intercourse.</li>
    <li style="margin-top:0.7ex;">1 = Mild; I can tolerate the discomfort during sexual intercourse.</li>
    <li style="margin-top:0.7ex;">2 = Moderate; Intercourse is sometime interrupted due to pain.</li>
    <li style="margin-top:0.7ex;">3 = Severe; I prefer to avoid intercourse because of pain.</li>
    <li style="margin-top:0.7ex;">Not applicable. I am not sexually active for reasons other than my endometriosis symptoms.</li>
  </ul>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and Weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in Dyspareunia Component of
 the Composite Pelvic Signs and Symptoms Score (CPSSS)&nbsp;            
            <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;37&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;37&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;31&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.19&nbsp;&nbsp;(0.12)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.21&nbsp;&nbsp;(0.12)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.56&nbsp;&nbsp;(0.13)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;34&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;37&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;25&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.15&nbsp;&nbsp;(0.12)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.68&nbsp;&nbsp;(0.12)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.66&nbsp;&nbsp;(0.14)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;32&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;35&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;28&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.29&nbsp;&nbsp;(0.13)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.67&nbsp;&nbsp;(0.12)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.49&nbsp;&nbsp;(0.14)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical 
analysis provided for Change From Baseline in Dyspareunia Component of 
the Composite Pelvic Signs and Symptoms Score (CPSSS)</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome19" id="outcome19"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">19.&nbsp; Secondary: &nbsp; </td>
            <td>Patient Global Impression of Change at Weeks 4, 8 and 12 &nbsp; [ Time Frame: Weeks 4, 8, and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Patient Global Impression of Change at Weeks 4, 8 and 12</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 Patient Global Impression of Change (PGIC) is a questionnaire-based 
assessment of the change in endometriosis pain since the initiation of 
study drug. The participant was asked to select from one of seven 
response categories:</p>
  <ol style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">Very Much Improved</li>
    <li style="margin-top:0.7ex;">Much Improved</li>
    <li style="margin-top:0.7ex;">Minimally Improved</li>
    <li style="margin-top:0.7ex;">Not Changed</li>
    <li style="margin-top:0.7ex;">Minimally Worse</li>
    <li style="margin-top:0.7ex;">Much Worse</li>
    <li style="margin-top:0.7ex;">Very Much Worse</li>
  </ol>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Patient Global Impression of Change at Weeks 4, 8 and 12&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;3.4&nbsp;&nbsp;(0.2)&nbsp;    
                                                                        
                          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;3.0&nbsp;&nbsp;(0.2)&nbsp;    
                                                                        
                          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;2.8&nbsp;&nbsp;(0.2)&nbsp;    
                                                                        
                          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;46&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;3.0&nbsp;&nbsp;(0.2)&nbsp;    
                                                                        
                          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;2.3&nbsp;&nbsp;(0.1)&nbsp;    
                                                                        
                          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;2.4&nbsp;&nbsp;(0.2)&nbsp;    
                                                                        
                          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;3.2&nbsp;&nbsp;(0.2)&nbsp;    
                                                                        
                          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;2.2&nbsp;&nbsp;(0.2)&nbsp;    
                                                                        
                          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;2.2&nbsp;&nbsp;(0.2)&nbsp;    
                                                                        
                          </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Patient Global Impression of Change at Weeks 4, 8 and 12</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome20" id="outcome20"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">20.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants With a PGIC Response of 
Minimally Improved, Much Improved, or Very Much Improved &nbsp; [ Time 
Frame: Weeks 4, 8, and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Participants With a PGIC Response of Minimally Improved, Much Improved, or Very Much Improved</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 Patient Global Impression of Change (PGIC) is a questionnaire-based 
assessment of the change in endometriosis pain since the initiation of 
study drug. The participant was asked to select from one of seven 
response categories:</p>
  <ol style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">Very Much Improved</li>
    <li style="margin-top:0.7ex;">Much Improved</li>
    <li style="margin-top:0.7ex;">Minimally Improved</li>
    <li style="margin-top:0.7ex;">Not Changed</li>
    <li style="margin-top:0.7ex;">Minimally Worse</li>
    <li style="margin-top:0.7ex;">Much Worse</li>
    <li style="margin-top:0.7ex;">Very Much Worse</li>
  </ol>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants With a PGIC Response 
of Minimally Improved, Much Improved, or Very Much Improved&nbsp;       
                 <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br>Number (95% Confidence Interval)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;54.2&nbsp;<br>
                                      &nbsp;(40.1&nbsp;to&nbsp;68.3)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;62.0&nbsp;<br>
                                      &nbsp;(48.5&nbsp;to&nbsp;75.5)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;80.0&nbsp;<br>
                                      &nbsp;(68.9&nbsp;to&nbsp;91.1)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;46&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;67.4&nbsp;<br>
                                      &nbsp;(53.8&nbsp;to&nbsp;80.9)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;91.7&nbsp;<br>
                                      &nbsp;(83.8&nbsp;to&nbsp;99.5)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;84.4&nbsp;<br>
                                      &nbsp;(73.9&nbsp;to&nbsp;95.0)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;60.0&nbsp;<br>
                                      &nbsp;(44.8&nbsp;to&nbsp;75.2)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;88.9&nbsp;<br>
                                      &nbsp;(79.7&nbsp;to&nbsp;98.1)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;82.2&nbsp;<br>
                                      &nbsp;(71.1&nbsp;to&nbsp;93.4)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical 
analysis provided for Percentage of Participants With a PGIC Response of
 Minimally Improved, Much Improved, or Very Much Improved</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome21" id="outcome21"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">21.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants With a PGIC Response of Much Improved or Very Much Improved &nbsp; [ Time Frame: Weeks 4, 8, and 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Participants With a PGIC Response of Much Improved or Very Much Improved</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 Patient Global Impression of Change (PGIC) is a questionnaire-based 
assessment of the change in endometriosis pain since the initiation of 
study drug. The participant was asked to select from one of seven 
response categories:</p>
  <ol style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">Very Much Improved</li>
    <li style="margin-top:0.7ex;">Much Improved</li>
    <li style="margin-top:0.7ex;">Minimally Improved</li>
    <li style="margin-top:0.7ex;">Not Changed</li>
    <li style="margin-top:0.7ex;">Minimally Worse</li>
    <li style="margin-top:0.7ex;">Much Worse</li>
    <li style="margin-top:0.7ex;">Very Much Worse</li>
  </ol>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Weeks 4, 8, and 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants With a PGIC Response 
of Much Improved or Very Much Improved&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br>Number (95% Confidence Interval)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;12.5&nbsp;<br>
                                      &nbsp;(3.1&nbsp;to&nbsp;21.9)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;34.0&nbsp;<br>
                                      &nbsp;(20.9&nbsp;to&nbsp;47.1)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;38.0&nbsp;<br>
                                      &nbsp;(24.5&nbsp;to&nbsp;51.5)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;46&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;37.0&nbsp;<br>
                                      &nbsp;(23.0&nbsp;to&nbsp;50.9)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;58.3&nbsp;<br>
                                      &nbsp;(44.4&nbsp;to&nbsp;72.3)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;60.0&nbsp;<br>
                                      &nbsp;(45.7&nbsp;to&nbsp;74.3)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;32.5&nbsp;<br>
                                      &nbsp;(18.0&nbsp;to&nbsp;47.0)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;66.7&nbsp;<br>
                                      &nbsp;(52.9&nbsp;to&nbsp;80.4)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;62.2&nbsp;<br>
                                      &nbsp;(48.1&nbsp;to&nbsp;76.4)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percentage of Participants With a PGIC Response of Much Improved or Very Much Improved</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome22" id="outcome22"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">22.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in Endometriosis Health Profile-5 (EHP-5) at Week 12 &nbsp; [ Time Frame: Baseline and week 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in Endometriosis Health Profile-5 (EHP-5) at Week 12</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image with
 five response categories for each item (Never, Rarely, Sometimes, 
Often, Always)</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions which assess the areas of work, 
relationship with children, sexual intercourse, feelings about the 
medical profession, treatment, and infertility with the same five 
response categories plus an additional response category of Not Relevant
 which was not scored.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">The scores associated 
with each possible outcome category are as follows: never (0), rarely 
(25), sometimes (50), often (75), and always (100). A negative change 
from baseline score indicates improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and week 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and reported at least 10 e-Diary NRS values during the initial 12 week 
treatment period. The analysis includes participants with non-missing 
data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;52&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in Endometriosis Health Profile-5 (EHP-5) at Week 12&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Pain&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;42&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Pain&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-11.8&nbsp;&nbsp;(3.6)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.0&nbsp;&nbsp;(3.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.3&nbsp;&nbsp;(4.0)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Control and Powerlessness&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;42&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Control and Powerlessness&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-10.5&nbsp;&nbsp;(4.7)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.6&nbsp;&nbsp;(3.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-22.6&nbsp;&nbsp;(4.8)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Emotional Wellbeing&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;42&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Emotional Wellbeing&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-6.6&nbsp;&nbsp;(4.0)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.2&nbsp;&nbsp;(3.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-9.5&nbsp;&nbsp;(4.8)&nbsp;   
                                                                        
                           </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Social Support&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;42&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Social Support&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.4&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.0&nbsp;&nbsp;(4.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-15.5&nbsp;&nbsp;(4.8)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Self-image&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;42&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Self-image&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-9.9&nbsp;&nbsp;(3.1)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.9&nbsp;&nbsp;(3.7)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-10.7&nbsp;&nbsp;(4.0)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Work&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;36&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;35&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Work&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-6.9&nbsp;&nbsp;(4.2)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.8&nbsp;&nbsp;(3.9)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-22.1&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Relationship with Children&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;25&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;27&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;16&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Relationship with Children&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-7.0&nbsp;&nbsp;(5.3)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.0&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.3&nbsp;&nbsp;(5.2)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Sexual Intercourse&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;33&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;39&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;28&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Sexual Intercourse&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-9.8&nbsp;&nbsp;(4.6)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.1&nbsp;&nbsp;(3.9)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-19.6&nbsp;&nbsp;(5.5)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Medical Profession&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;32&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;34&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Medical Profession&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;0.0&nbsp;&nbsp;(3.7)&nbsp;    
                                                                        
                          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.5&nbsp;&nbsp;(3.9)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-14.0&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Frustration with Treatment&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;42&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;41&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Frustration with Treatment&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-8.6&nbsp;&nbsp;(4.7)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.2&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.2&nbsp;&nbsp;(5.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Concerns with Infertility&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;28&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;34&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;33&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Concerns with Infertility&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-9.8&nbsp;&nbsp;(4.1)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.1&nbsp;&nbsp;(4.1)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-9.1&nbsp;&nbsp;(4.0)&nbsp;   
                                                                        
                           </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in Endometriosis Health Profile-5 (EHP-5) at Week 12</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome23" id="outcome23"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">23.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline in Bone Mineral Density of the Femur at Week 12 &nbsp; [ Time Frame: Baseline and week 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline in Bone Mineral Density of the Femur at Week 12</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Bone mineral density (BMD) of 
the femur (total hip) was measured by dual-energy X-ray absorptiometry 
(DXA).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and week 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and with available BMD data at baseline and week 12.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;37&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;42&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;43&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline in Bone Mineral 
Density of the Femur at Week 12&nbsp;                        <br><span class="body3">[Units:&nbsp;Percent&nbsp;change]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.283&nbsp;&nbsp;(1.851)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.294&nbsp;&nbsp;(1.762)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.382&nbsp;&nbsp;(1.338)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percent Change From Baseline in Bone Mineral Density of the Femur at Week 12</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome24" id="outcome24"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">24.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline in Bone Mineral Density of the Femur at Week 24 &nbsp; [ Time Frame: Baseline and Week 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline in Bone Mineral Density of the Femur at Week 24</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Bone mineral density (BMD) of 
the femur (total hip) was measured by dual-energy X-ray absorptiometry 
(DXA).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and Week 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and with available BMD data at baseline and week 24.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo / Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants initially randomized to placebo 
were re-randomized at week 12 to receive elagolix 150 mg for 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo / Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants initially randomized to placebo 
were re-randomized at week 12 to receive elagolix 250 mg for 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo / Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo / Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;37&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;37&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;13&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;17&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline in Bone Mineral 
Density of the Femur at Week 24&nbsp;                        <br><span class="body3">[Units:&nbsp;Percent&nbsp;change]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.743&nbsp;&nbsp;(1.877)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.024&nbsp;&nbsp;(1.759)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.924&nbsp;&nbsp;(1.198)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.076&nbsp;&nbsp;(2.362)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percent Change From Baseline in Bone Mineral Density of the Femur at Week 24</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome25" id="outcome25"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">25.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline in Bone Mineral Density of the Spine at Week 12 &nbsp; [ Time Frame: Baseline and week 12 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline in Bone Mineral Density of the Spine at Week 12</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Bone mineral density (BMD) of 
the spine was measured by dual-energy X-ray absorptiometry (DXA).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and week 12 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and with available BMD data at baseline and week 12.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo tablets once a 
day for 12 weeks. At the end of 12 weeks participants were re-randomized
 to receive one of the two doses of elagolix (150 mg or 250 mg) QD for 
12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;36&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;43&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;42&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline in Bone Mineral 
Density of the Spine at Week 12&nbsp;                        <br><span class="body3">[Units:&nbsp;Percent&nbsp;change]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;0.375&nbsp;&nbsp;(2.091)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.045&nbsp;&nbsp;(2.088)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.937&nbsp;&nbsp;(2.747)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percent Change From Baseline in Bone Mineral Density of the Spine at Week 12</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome26" id="outcome26"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">26.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline in Bone Mineral Density of the Spine at Week 24 &nbsp; [ Time Frame: Baseline and Week 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline in Bone Mineral Density of the Spine at Week 24</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Bone mineral density (BMD) of 
the spine was measured by dual-energy X-ray absorptiometry (DXA).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and Week 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one dose of randomized, double-blind study drug 
and with available BMD data at baseline and week 24.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 150 mg QD for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 250 mg tablets 
once a day for 12 weeks. At the end of 12 weeks participants continued 
to receive elagolix 250 mg for an additional 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo / Elagolix 150 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants initially randomized to placebo 
were re-randomized at week 12 to receive elagolix 150 mg for 12 weeks.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo / Elagolix 250 mg</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants initially randomized to placebo 
were re-randomized at week 12 to receive elagolix 250 mg for 12 weeks.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 250 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo / Elagolix 150 mg&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo / Elagolix 250 mg&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;38&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;37&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;14&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;15&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline in Bone Mineral 
Density of the Spine at Week 24&nbsp;                        <br><span class="body3">[Units:&nbsp;Percent&nbsp;change]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.032&nbsp;&nbsp;(1.983)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.631&nbsp;&nbsp;(2.874)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.692&nbsp;&nbsp;(1.724)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;0.681&nbsp;&nbsp;(2.720)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percent Change From Baseline in Bone Mineral Density of the Spine at Week 24</span>
                <br>

                            <br>
              <br>
                              </div>
          </div>
</div>
  
<!-- adverse events section -->
<br>
<div class="indent1">

  <br>
  <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Serious Adverse Events</span><br>
  <a name="evnt" id="evnt"></a>
  <div class="header3 indent2">

      <div style="margin-top:1.0ex;">
      <a title="Show serious adverse events" href="https://clinicaltrials.gov/ct2/show/results/NCT00619866?sect=X301256#evnt">
        <img style="float:left" src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/plus.gif" alt="" border="0"> &nbsp; Show Serious Adverse Events
      </a>
    </div>
      </div>

  <br>
  <br>
  <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Other Adverse Events</span>
  <a name="othr" id="othr"></a>
  <div class="header3 indent2">

      <div style="margin-top:1.0ex;">
      <a title="Show other adverse events" href="https://clinicaltrials.gov/ct2/show/results/NCT00619866?sect=X401256#othr">
        <img style="float:left" src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/plus.gif" alt="" border="0"> &nbsp; Show Other Adverse Events
      </a>
    </div>
      </div>
</div>
  
<!-- limitations and caveats section -->
<div class="indent1">

  <br>
  <br>
  <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Limitations and Caveats</span>

  <a name="limit" id="limit"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">
      <a title="Hide Limitations and Caveats" href="https://clinicaltrials.gov/ct2/show/results/NCT00619866?sect=X0126#limit">
        <img style="float:left" src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide Limitations and Caveats
      </a>
    </div>

    <br>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_more_info_color" style="text-align:left;">
          Limitations of the study, such as early termination leading to small numbers of participants
          analyzed and technical problems with measurement leading to unreliable or uninterpretable data
        </th>
      </tr>
      <tr>
        <td class="body3 pale_more_info_color" style="vertical-align:top;">
                      No text entered.
                  </td>
      </tr>
    </tbody></table>

    </div>
</div>
  
<!-- more results info section -->
<br>
<div class="indent1">

  <br>
  <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; More Information</span>
  <a name="more" id="more"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">
      <a title="Hide more information" href="https://clinicaltrials.gov/ct2/show/results/NCT00619866?sect=X0125#more">
        <img style="float:left" src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide More Information
      </a>
    </div>

    <br>
    <div class="body3">

          <span class="header3">Certain Agreements: &nbsp; </span>
      <table class="layout_table" style="margin-top:0.5ex; border:1px solid #ccc;" width="100%" cellspacing="0" cellpadding="5">
              <tbody><tr>
          <td class="body3 pale_more_info_color">
                          Principal Investigators are <b>NOT</b> employed by the organization sponsoring the study.
                      </td>
        </tr>
      
              <tr>
          <td class="body3 pale_more_info_color">
                          There <b>IS</b> an agreement between Principal Investigators and the Sponsor (or its agents) that restricts
              the PI's rights to discuss or publish trial results after the trial is completed.
                      </td>
        </tr>
      
              <tr>
          <td class="body3 pale_more_info_color">
          The agreement is:<br>

          <table class="layout_table" cellspacing="0" cellpadding="5" border="0">
            <tbody><tr style="vertical-align:middle;">
              <td class="header1" style="white-space:nowrap;">
                <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/uncheck.gif" alt="unchecked">              </td>
              <td class="body3">
                The only disclosure restriction on the PI is that the 
sponsor can review results communications prior to public release
                and can embargo communications regarding trial results 
for a period that is <b>less than or equal to 60 days</b>.
                The sponsor cannot require changes to the communication and cannot extend the embargo.
              </td>
            </tr>
            <tr style="vertical-align:middle;">
              <td class="header1" style="white-space:nowrap;">
                <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/uncheck.gif" alt="unchecked">              </td>
              <td class="body3">
                The only disclosure restriction on the PI is that the 
sponsor can review results communications prior to public release
                and can embargo communications regarding trial results 
for a period that is <b>more than 60 days but less than
                or equal to 180 days</b>. The sponsor cannot require changes to the communication and cannot extend the embargo.
              </td>
            </tr>
            <tr class="banner_color" style="vertical-align:middle;">
              <td class="header1" nowrap="nowrap">
                <img src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/check.gif" alt="checked">              </td>
              <td class="body3">
                Other disclosure agreement that restricts the right of 
the PI to discuss or publish trial results after the trial is completed.
                                  <br>
                  <br>
                  <span class="header3">Restriction Description:</span> 
&nbsp;
                                      AbbVie requests that any 
investigator or institution that plans on presenting/publishing results 
disclosure, provide written notification of their request 60 days prior 
to their presentation/publication. AbbVie requests that no 
presentation/publication will be instituted until 12 months after a 
study is completed, or after the first presentation/publication 
whichever occurs first. A delay may be proposed of a 
presentation/publication if AbbVie needs to secure patent or proprietary
 protection.
                                                </td>
            </tr>
          </tbody></table>
          </td>
        </tr>
            </tbody></table>
    
    <br>
          <br>
            <span class="header3">Results Point of Contact: &nbsp; </span>
      <div class="indent2" style="margin-top:1ex">
        Name/Title: Global Medical Services<br>
                  Organization: AbbVie<br>
                          phone: 800-633-9110<br>
                      </div>
      <br>
    
    <br>

    
    
    
    <br>
    <table class="layout_table" cellspacing="0" cellpadding="0" border="0">
            <tbody><tr style="vertical-align:top;">
        <td nowrap="nowrap">Responsible Party:</td>
        <td style="padding-left:1em">AbbVie</td>
      </tr>
            <tr style="vertical-align:top;">
        <td nowrap="nowrap">ClinicalTrials.gov Identifier:</td>
        <td style="padding-left:1em">
          <a title="Current version of study NCT00619866 on ClinicalTrials.gov" href="https://clinicaltrials.gov/show/NCT00619866">NCT00619866</a> &nbsp; &nbsp;
          <a href="https://clinicaltrials.gov/ct2/archive/NCT00619866" title="Historical versions of study NCT00619866 on ClinicalTrials.gov Archive Site" onclick="openNewWindow('/ct2/archive/NCT00619866'); return false;">History of Changes</a>
        </td>
      </tr>
                  <tr style="vertical-align:top;">
        <td headers="colTitle" nowrap="nowrap">Other Study ID Numbers:</td>
        <td headers="colData" style="padding-left:1em">
                                    NBI-56418-0702 <br>
                              </td>
      </tr>
      
            <tr style="vertical-align:top;">
        <td nowrap="nowrap">First Submitted:</td>
        <td style="padding-left:1em">January 24, 2008</td>
      </tr>
                  <tr style="vertical-align:top;">
        <td nowrap="nowrap">First Posted:</td>
        <td style="padding-left:1em">February 21, 2008</td>
      </tr>
                  <tr style="vertical-align:top;">
        <td nowrap="nowrap">Results First Submitted:</td>
        <td style="padding-left:1em">August 9, 2018</td>
      </tr>
                  <tr style="vertical-align:top;">
        <td nowrap="nowrap">Results First Posted:</td>
        <td style="padding-left:1em">September 7, 2018</td>
      </tr>
            <tr style="vertical-align:top;">
        <td nowrap="nowrap">Last Update Posted:</td>
        <td style="padding-left:1em">September 7, 2018
        </td>
      </tr>

    </tbody></table>

    </div>
    </div>
</div>

<br>
<br>
<br>
</div>
<div id="to-top"><a href="#wrapper">To Top</a></div>
</div>


	<div style="clear:both;"></div>
</div> 

<div>       <div id="for-footer">
        <ul class="horz-list">
            <li style="border-left:0;"><a href="https://clinicaltrials.gov/ct2/help/for-patient">For Patients and Families</a></li>
            <li><a href="https://clinicaltrials.gov/ct2/help/for-researcher">For Researchers</a></li>
            <li><a href="https://clinicaltrials.gov/ct2/help/for-manager">For Study Record Managers</a></li>
        </ul>
    </div>

</div>  
<div id="footer-menu">
    <ul class="horz-list" style="padding-bottom:1.5ex;">
		<li><a href="https://clinicaltrials.gov/ct2/home" style="white-space:nowrap">Home</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/resources/rss" style="white-space:nowrap">RSS Feeds</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/sitemap" style="white-space:nowrap">Site Map</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/about-site/terms-conditions" style="white-space:nowrap">Terms and Conditions</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer" style="white-space:nowrap">Disclaimer</a></li>
		<li><a href="https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT00619866%3Fsect%3DX01256" style="white-space:nowrap" onclick="openNewWindow('https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT00619866%3Fsect%3DX01256'); return false">Customer Support</a></li>
	</ul>
</div>

</div>  
<div id="fine-print">
	<ul class="horz-list">
		<li><a title="NLM copyright information - opens new window" href="https://www.nlm.nih.gov/copyright.html" onclick="openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false">Copyright</a></li>
		<li><a title="NLM privacy policy - opens new window" href="https://www.nlm.nih.gov/privacy.html" onclick="openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false">Privacy</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/accessibility" title="NLM Accessibility">Accessibility</a></li>
		<li><a title="NLM viewers and players - opens new window" href="https://www.nlm.nih.gov/plugins.html" onclick="openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false">Viewers and Players</a></li>
		<li><a title="NIH Freedom of Information Act office - opens new window" href="https://www.nih.gov/icd/od/foia/index.htm" onclick="openNewWindow('https://www.nih.gov/icd/od/foia/index.htm'); return false">Freedom of Information Act</a></li>
		<li class="last-item"><a title="USA.gov - opens new window" href="https://www.usa.gov/" onclick="openNewWindow('https://www.usa.gov/'); return false">USA.gov</a></li>
	</ul>
    <ul class="horz-list">
       <li><a title="U.S. National Library of Medicine - opens new window" href="https://www.nlm.nih.gov/" onclick="openNewWindow('https://www.nlm.nih.gov/'); return false">U.S. National Library of Medicine</a></li>
       <li><a title="U.S. National Institutes of Health - opens new window" href="https://www.nih.gov/" onclick="openNewWindow('https://www.nih.gov/'); return false">U.S. National Institutes of Health</a></li>
       <li class="last-item"><a title="U.S. Department of Health and Human Services - opens new window" href="https://www.hhs.gov/" onclick="openNewWindow('https://www.hhs.gov/'); return false">
            U.S. Department of Health and Human Services</a></li>
    </ul>
</div>

<script type="text/javascript">__ncbi_sg_gaMode="clinicaltrials"</script>
<script type="text/javascript" src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/instrumentNCBIBaseJS.js"></script><script async="1" src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/analytics.js"></script><noscript></noscript>
<script type="text/javascript" src="An%20Efficacy%20and%20Safety%20Study%20of%20Elagolix%20(NBI-56418)%20in%20Women%20With%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/main-glossary.js"></script><noscript></noscript>



<ul class="print-log"><li></li></ul></body></html>